Partnership Between MAIA Biotechnology and Cromos Pharma

Successful Partnership Between MAIA Biotechnology and Cromos Pharma

MAIA Biotechnology and Cromos Pharma have partnered up in an innovative collaboration to advance cancer treatment. Mutual collaborative efforts are focused on THIO, a groundbreaking telomere-targeting agent for non-small cell lung cancer (NSCLC). In a trial presented at ASCO 2024, THIO demonstrated an impressive 85% disease control rate.

Read more in the press release: https://www.pr.com/press-release/914337


Cromos Pharma proudly supports the Right2hope nonprofit platform, empowering patients to explore treatment options beyond traditional clinical trials. Through an intuitive, AI-supported matching algorithm, Right2hope connects patients with the most relevant expanded access, compassionate use, and right-to-try programs.

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us

OUR PUBLICATIONS